Management of a 16-Year-Old Male with Type 1 PUV, Post-Circumcision, CKD with ~80% Renal Damage on Dialysis

1. Confirm and Assess Current Status

• Serum creatinine, BUN, eGFR (GFR likely <15 mL/min/1.73 m² given 80% damage)
• Electrolytes (Na, K, bicarbonate, phosphate, calcium)
• Urine output and residual urine volume assessment
• 24-hour urine protein (proteinuria is a major progression marker)
• Blood pressure monitoring (hypertension is nearly universal)
• Serum PTH, vitamin D, FGF-23 (renal osteodystrophy screen)
• Hemoglobin and iron studies (anemia of CKD)

• Urine flow rate + post-void residual (check for urethral stricture - a complication of previous transurethral valve resection and circumcision)
• Urodynamics / videocystometrography - critical to assess bladder compliance, instability, and storage pressures. Bladder storage pressure must be kept <40 cm H₂O
• Renal ultrasound (upper tract status, hydronephrosis)
• Check bladder capacity (keep <400 mL)

2. Ongoing Dialysis Management

• Peritoneal dialysis (PD) vs Hemodialysis (HD)
• In adolescents, HD is often preferred as PD adherence can be challenging and prior abdominal surgeries may affect PD catheter placement
• HD via arteriovenous fistula (preferred) or tunneled central venous catheter
• Dialysis dose optimization - target Kt/V ≥1.2 per session for HD (3x/week minimum)

• Hyperkalemia: dietary K restriction + patiromer/sodium polystyrene sulfonate
• Metabolic acidosis: target serum bicarbonate 20-22 mEq/L (sodium bicarbonate supplementation)
• Hyperphosphatemia: phosphate binders (calcium carbonate, sevelamer)

3. Medical Management of CKD Complications

4. Urological / Bladder Management - Critical in PUV

• Clean intermittent catheterization (CIC): For significant post-void residual urine. Adherence is often poor in adolescents - counseling and support are mandatory
• Anticholinergic therapy: Oxybutynin or solifenacin to treat bladder instability and reduce storage pressures
• Alpha-blockers (tamsulosin): May help bladder neck relaxation, though recent reviews question whether it delays ESKD progression (PMID: 37348660)
• Urethral stricture exclusion: Prior valve resection and instrumentation can cause stricture - check urine flow rate
• Bladder augmentation (ileocystoplasty): May be required pre-transplant if bladder capacity/compliance cannot be corrected medically. This is a critical pre-transplant surgical decision

5. Kidney Transplantation - The Goal

• Transplantation offers far superior outcomes vs lifelong dialysis: improved growth, neurocognitive development, quality of life, and survival
• Acute rejection risk: <10% at 1 year for living-donor grafts, ~15% for deceased-donor
• PUV patients can be successfully transplanted but require careful pre-transplant urological preparation (PMID: 39089950)

• Full urodynamic assessment - the bladder must be suitable to receive the graft ureter
• Bladder capacity, compliance, and pressures must be optimized
• CIC must be established and the patient compliant
• Augmentation cystoplasty if bladder is non-compliant and cannot be corrected otherwise
• Crossmatch, HLA typing, panel reactive antibody (PRA)
• CMV/EBV/BK virus serology
• Nutritional and cardiovascular optimization
• Psychosocial readiness assessment (especially critical in adolescence)

• In patients >20 kg (adolescent), retroperitoneal placement with anastomosis to iliac vessels
• Anti-reflux ureteroneocystostomy
• Induction: thymoglobulin or basiliximab
• Maintenance immunosuppression: tacrolimus + mycophenolate mofetil ± steroids
• Prophylaxis: valganciclovir (CMV), TMP-SMX (PCP)

• Living related donor (parent/sibling) offers better outcomes - family evaluation should begin now

6. Transition Care - Critical at Age 16

• A dedicated transition clinic - both pediatric urologist and nephrologist must coordinate handover
• Adolescents may exhibit frustration having spent their life in hospitals - psychosocial support is key
• Education on their condition, the importance of medication adherence, bladder care, and CIC compliance
• Sexual and reproductive health counseling - fertility may be affected; retrograde ejaculation is possible due to dilated prostatic fossa from PUV

7. Long-Term Surveillance (Post-Transplant)

• Monitor eGFR, proteinuria, blood pressure regularly
• Routine BK virus and CMV surveillance
• Cancer surveillance: transplant recipients have ~7x higher risk for renal cell carcinoma, thyroid carcinoma, and skin malignancies
• Continued bladder surveillance and urodynamics post-transplant
• Psychological support through adolescence and into adulthood
• Regular bone density (prolonged CKD + steroids = osteoporosis risk)

Summary Algorithm

CURRENT STATUS: ESKD on dialysis (80% renal damage, Type 1 PUV)
         ↓
Step 1: Optimize dialysis adequacy + manage CKD complications
         ↓
Step 2: Full urodynamic bladder assessment
         ↓
Step 3: Optimize bladder with CIC ± anticholinergics ± bladder augmentation
         ↓
Step 4: Pre-transplant workup (HLA typing, cross-match, family donor eval)
         ↓
Step 5: KIDNEY TRANSPLANTATION (preferred over long-term dialysis)
         ↓
Step 6: Post-transplant immunosuppression, infection prophylaxis, surveillance
         ↓
Step 7: Long-term transition to adult care with urological + nephrological follow-up

• Campbell-Walsh-Wein Urology (PUV long-term outcomes and bladder management)
• Brenner & Rector's The Kidney (Pediatric ESKD, dialysis, and transplantation)
• Comprehensive Clinical Nephrology 7th Ed (PUV management principles)
• Recent reviews: PMID 39503773 (2025 - nephrology care post-PUV ablation) and PMID 39089950 (2024 - renal transplantation for congenital urological diseases)

Note: This is a medically complex adolescent requiring a multidisciplinary team: pediatric/adult nephrologist, pediatric urologist, transplant surgeon, dietitian, and psychologist. Definitive management decisions must be made in a transplant-capable center.